BRIEF published on 05/20/2024 at 15:58, 1 year 9 months ago Vanguard Group Discloses Interest in Anglo American Plc Disclosure Takeover Code Vanguard Group Shareholding Anglo American
BRIEF published on 05/20/2024 at 15:58, 1 year 9 months ago Vanguard Group dévoile son intérêt dans Anglo American Plc Actionnariat Divulgation Groupe D'avant-garde Code De Reprise Anglo-américain
BRIEF published on 05/20/2024 at 15:57, 1 year 9 months ago The Vanguard Group, Inc. Discloses Position in Smith (DS) plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Smith (DS) Plc
BRIEF published on 05/20/2024 at 15:57, 1 year 9 months ago The Vanguard Group, Inc. divulgue sa position dans Smith (DS) plc Smith (DS) Plc Groupe D'avant-garde Code De Reprise Formulaire 8.3 Divulgation Des Titres
BRIEF published on 05/20/2024 at 15:56, 1 year 9 months ago The Vanguard Group Discloses Position in Barratt Developments plc The Vanguard Group Takeover Code Shareholding Barratt Developments Investment Disclosure
BRIEF published on 05/20/2024 at 15:56, 1 year 9 months ago Le groupe Vanguard dévoile sa position dans Barratt Developments plc Actionnariat Le Groupe Vanguard Code De Reprise Développements Barratt Divulgation Des Investissements
BRIEF published on 05/20/2024 at 15:55, 1 year 9 months ago The Vanguard Group Discloses Position in BHP Group Limited Takeover Code Vanguard Group Form 8.3 Disclosure BHP Group Limited Stocks
BRIEF published on 05/20/2024 at 15:55, 1 year 9 months ago Le groupe Vanguard divulgue sa position dans BHP Group Limited Actions Groupe D'avant-garde Code De Reprise Divulgation Du Formulaire 8.3 Groupe BHP Limitée
BRIEF published on 05/20/2024 at 15:20, 1 year 9 months ago Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 Clinical Trials Cancer Treatment Immunotherapy Sonnet BioTherapeutics SON-1010
BRIEF published on 05/20/2024 at 15:20, 1 year 9 months ago Sonnet BioTherapeutics annonce des données cliniques mises à jour pour SON-1010 Immunothérapie Essais Cliniques Sonnet BioTherapeutics FILS-1010 Traitement Du Cancer
Published on 03/11/2026 at 23:00, 7 hours 23 minutes ago Redwood AI Enhances Its Chemical Synthesis Platform with Industry-Grade Integrated Safety Functionality, Streamlining User Chemical Development Processes
Published on 03/11/2026 at 22:55, 7 hours 28 minutes ago Pathfinder Ventures Announces Closing of Parksville Refinancing and Extension of Private Placement
Published on 03/11/2026 at 19:00, 11 hours 23 minutes ago Worksport Announces Fourth Quarter and Full Year 2025 Earnings Date; Updated Financial Guidance and Path to Cash-Flow Positivity to Be Discussed
Published on 03/12/2026 at 01:35, 4 hours 48 minutes ago Sky Labs Launches their support of the American Heart Association's 'Established Investigator Award for Clinical Hypertension'
Published on 03/11/2026 at 21:30, 8 hours 53 minutes ago KPS CAPITAL PARTNERS TO ACQUIRE A CONTROLLING INTEREST IN JENNMAR
Published on 03/11/2026 at 18:19, 12 hours 3 minutes ago Fuller, Smith & Turner PLC: TR-1: Standard form for notification of major holdings
Published on 03/11/2026 at 20:05, 10 hours 18 minutes ago CDA - Compte rendu de l'AG et du Conseil d'administration
Published on 03/11/2026 at 18:30, 11 hours 53 minutes ago Filing of the 2025 TF1 Universal Registration Document
Published on 03/11/2026 at 18:30, 11 hours 53 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025 de TF1
